InflaRx Management
Management criteria checks 2/4
InflaRx's CEO is Niels Riedemann, appointed in Jan 2007, has a tenure of 15.83 years. directly owns 2.42% of the company’s shares, worth €2.64M. The average tenure of the management team and the board of directors is 5.8 years and 5.7 years respectively.
Key information
Niels Riedemann
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 15.8yrs |
CEO ownership | 2.4% |
Management average tenure | 5.8yrs |
Board average tenure | 5.7yrs |
Recent management updates
Recent updates
CEO
Niels Riedemann (50 yo)
15.8yrs
Tenure
Prof. Dr. Niels C. Riedemann, M.D. is Chief Executive Officer of InflaRx N.V. since 2007 and serves as its Executive Director. Dr. Riedemann founded InflaRx N.V. in 2007 as InflaRx GmbH. Dr. Riedemann spen...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.8yrs | no data | 2.42% € 2.6m | |
Co-Founder | 15.8yrs | no data | 3.87% € 4.2m | |
Chief Financial Officer | 2.1yrs | no data | 0.0079% € 8.7k | |
Senior Director & Head of Human Resources | 1.7yrs | no data | no data | |
Head of Preclinical Research & Development | 9.8yrs | no data | no data | |
VP & Head of Clinical Operations | 5.8yrs | no data | no data | |
VP & Head of Medical Affairs | no data | no data | no data | |
VP and Head of Legal Affairs & Corporate Counsel | no data | no data | no data | |
Senior Director and Head of Supply & Clinical Trial Supplies | no data | no data | no data | |
Senior Director and Head of Drug Safety & Pharmacovigiliance | no data | no data | no data | |
Senior Director & Head of IT | less than a year | no data | no data | |
VP and Head of Finance & Controlling | no data | no data | no data |
5.8yrs
Average Tenure
51yo
Average Age
Experienced Management: IF0's management team is seasoned and experienced (5.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | no data | no data | 2.42% € 2.6m | |
Co-Founder | no data | no data | 3.87% € 4.2m | |
Independent Chairman of the Board | 15.8yrs | no data | 1.06% € 1.2m | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Non-Executive Director | 3.5yrs | no data | 0.11% € 123.7k | |
Independent Non-Executive Director | 7.8yrs | no data | 2.17% € 2.4m | |
Independent Non-Executive Director | 1.5yrs | no data | 0.023% € 24.7k |
5.7yrs
Average Tenure
50.5yo
Average Age
Experienced Board: IF0's board of directors are considered experienced (5.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/11/16 13:50 |
End of Day Share Price | 2022/08/19 00:00 |
Earnings | 2022/09/30 |
Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
InflaRx N.V. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Madhu Kumar | Baird |
Mayur Somaiya | BMO Capital Markets Equity Research |
Madhu Kumar | B. Riley Securities, Inc. |